APA

Yaghootkar H., Stancáková A., Freathy R. M., Vangipurapu J., Weedon M. N., Xie W., Wood A. R., Ferrannini E., Mari A., Ring S. M., Lawlor D. A., Davey Smith G., Jørgensen T., Hansen T., Pedersen O., Steinthorsdottir V., Guðbjartsson D. F., Thorleifsson G., Thorsteinsdottir U., Stefansson K., Hattersley A. T., Walker M., Morris A. D., McCarthy M. I., Palmer C. N. A., Laakso M. & Frayling T. M. (20150819). Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. : Diabetes.

Chicago

Yaghootkar Hanieh, Stancáková Alena, Freathy Rachel M, Vangipurapu Jagadish, Weedon Michael N, Xie Weijia, Wood Andrew R, Ferrannini Ele, Mari Andrea, Ring Susan M, Lawlor Debbie A, Davey Smith George, Jørgensen Torben, Hansen Torben, Pedersen Oluf, Steinthorsdottir Valgerdur, Guðbjartsson Daniel F, Thorleifsson Gudmar, Thorsteinsdottir Unnur, Stefansson Kari, Hattersley Andrew T, Walker Mark, Morris Andrew D, McCarthy Mark I, Palmer Colin N A, Laakso Markku and Frayling Timothy M. 20150819. Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. : Diabetes.

Harvard

Yaghootkar H., Stancáková A., Freathy R. M., Vangipurapu J., Weedon M. N., Xie W., Wood A. R., Ferrannini E., Mari A., Ring S. M., Lawlor D. A., Davey Smith G., Jørgensen T., Hansen T., Pedersen O., Steinthorsdottir V., Guðbjartsson D. F., Thorleifsson G., Thorsteinsdottir U., Stefansson K., Hattersley A. T., Walker M., Morris A. D., McCarthy M. I., Palmer C. N. A., Laakso M. and Frayling T. M. (20150819). Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. : Diabetes.

MLA

Yaghootkar Hanieh, Stancáková Alena, Freathy Rachel M, Vangipurapu Jagadish, Weedon Michael N, Xie Weijia, Wood Andrew R, Ferrannini Ele, Mari Andrea, Ring Susan M, Lawlor Debbie A, Davey Smith George, Jørgensen Torben, Hansen Torben, Pedersen Oluf, Steinthorsdottir Valgerdur, Guðbjartsson Daniel F, Thorleifsson Gudmar, Thorsteinsdottir Unnur, Stefansson Kari, Hattersley Andrew T, Walker Mark, Morris Andrew D, McCarthy Mark I, Palmer Colin N A, Laakso Markku and Frayling Timothy M. Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. : Diabetes. 20150819.